FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Proteins patents



      
           
This page is updated frequently with new Proteins-related patent applications. Subscribe to the Proteins RSS feed to automatically get the update: related Proteins RSS feeds. RSS updates for this page: Proteins RSS RSS


Systems and methods for treating dermatological imperfections

Systems and methods for treating dermatological imperfections

Date/App# patent app List of recent Proteins-related patents
12/11/14
20140366227
 Pesticides patent thumbnailPesticides
The present invention relates to the development of fusion proteins based on peptide toxins as pesticides. The invention also relates to transgenic plants encoding said peptides and their utility in pest management..
12/11/14
20140366225
 Endogenous regulator of rna silencing in plants patent thumbnailEndogenous regulator of rna silencing in plants
Compositions and methods are described which use rav proteins and genes that encode such proteins to regulate rna silencing in plant cells. Novel ntrav proteins and genes are also described..
12/11/14
20140364924
 Systems and methods for treating dermatological imperfections patent thumbnailSystems and methods for treating dermatological imperfections
Provided are dermatological medical devices and methods comprising a distal end for positioning at a region proximal a target therapeutic region of tissue, an output port at the distal end, an energy source that generates optical energy, which is output from the output port to the target therapeutic region of tissue, and a control device that controls the optical energy at the target therapeutic region of tissue for increasing a temperature of the target therapeutic region of tissue for a period of time to a temperature that is less than an injuring temperature and induces an expression of heat shock proteins (hsps) at the target therapeutic region of tissue.. .
12/11/14
20140364507
 Methods for identifying inhibitors of mannan-binding lectin-associated serine protease (masp) proteins and uses thereof patent thumbnailMethods for identifying inhibitors of mannan-binding lectin-associated serine protease (masp) proteins and uses thereof
This disclosure is directed to methods and compositions to inhibit masp protein activity using small molecule inhibitors. In one aspect, the disclosure is directed to methods for identifying inhibitors of masp protein activity, including methods of screening capable of inhibiting masp protein activity..
12/11/14
20140364458
 Use of an anthranilic diamide derivatives with heteroaromatic and heterocyclic substituents in combination with a biologicalcontrol agent patent thumbnailUse of an anthranilic diamide derivatives with heteroaromatic and heterocyclic substituents in combination with a biologicalcontrol agent
In which r1, r2, r3, r4, r5, r6, a, q and n can have the definitions stated in the description, and at least one biological control agent selected from bacteria, fungi or yeasts, protozoas, viruses, entomopathogenic nematodes, and botanical extracts, or products produced by microorganisms including proteins or secondary metabolites, and optionally an inoculant, for reducing overall damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by insects, nematodes and phytopathogens.. .
12/11/14
20140364337
 Absolute quantitation of proteins and protein modifications by mass spectrometry with multiplexed internal standards patent thumbnailAbsolute quantitation of proteins and protein modifications by mass spectrometry with multiplexed internal standards
A method for absolute protein or peptide quantitation by mass spectroscopy. A sample containing a protein or peptide of interest is prepared for mass spectroscopy analysis.
12/11/14
20140364329
 Methods for identifying protein-protein interactions patent thumbnailMethods for identifying protein-protein interactions
The invention generally relates to methods for identifying protein-protein interactions. In certain aspects, methods of the invention involve conducting a protein-fragment complementation assay on a sample to form a protein-protein complex between two proteins in the sample that only transiently interact under physiological conditions, separating the complexes from the sample, and analyzing a protein of the complex using a mass spectrometry technique..
12/11/14
20140364309
 Active compounds combination containing fluopyram bacillus and biologically control agent patent thumbnailActive compounds combination containing fluopyram bacillus and biologically control agent
The present invention relates to active compound combinations and compostions for reducing the damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by insects, nematodes or phytopathogens and which have fungicidal or nematicidal or insecticidal activity including any combination of the three activities, in particular within a composition, which comprises (a) fluopyram, (b) a spore-forming bacterium of the genera bacillus, selected from bacillus firmus, bacillus cereus, bacillus pumilis, bacillus amyloliquefaciens, bacillus subtilis strain gb03, bacillus subtilis strain qst713, and (c) at least one biological control agent, in particular bacteria, fungi or yeasts, protozoa, viruses, entomopathogenic nematodes, inoculants, botanicals and products produced by microorganisms including proteins or secondary to metabolites. Moreover, the invention relates to a method for curatively or preventively controlling insects, nematodes or phytopathogens on the plant, plant parts, harvested fruits or vegetables, to the use of a combination according to the invention for the treatment of seed, to a method for protecting a seed and not at least to the treated seed..
12/11/14
20140363614
 Adhesive comprising partly hydrolyzed proteins and metal silicates patent thumbnailAdhesive comprising partly hydrolyzed proteins and metal silicates
The present invention relates to a liquid adhesive composition comprising a partly hydrolyzed protein component, having a degree of hydrolysis (dh) in the range 0.2-2; a metal silicate component; optionally, an exogenic protein hydrolyzing component; and wherein the liquid adhesive composition has a solid content in the range 15-80% by weight.. .
12/11/14
20140363522
 Compositions and methods for treating and/or preventing cancer by inhibiting fatty acid binding proteins patent thumbnailCompositions and methods for treating and/or preventing cancer by inhibiting fatty acid binding proteins
The present invention concerns methods and compositions for the inhibition or reduction of the primary tumor and metastasis by inhibition of fatty acid binding proteins.. .
12/11/14
20140363470
Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
The present invention relates to compositions which can be used in immunotherapy and especially to compositions which can be used in immunotherapy for mammals, such as human mammals, suffering from peanut allergy. The present invention further relates to the use of the present compositions for the therapeutic treatment for desentizing the immune system of a mammal suffering from an allergy by immunotherapy and the use of the present compositions in a prophylactic treatment of a mammal with high predisposition to develop a certain allergy.
12/11/14
20140363462
Heterologous expression of neisserial proteins
Alternative and improved approaches to the heterologous expression of the proteins of neisseria meningitidis and neisseria gonorrhoeae are disclosed. These approaches typically affect the level of expression, the ease of purification, the cellular localization, and/or the immunological properties of the expressed protein..
12/11/14
20140363459
Synthetic capsid proteins and uses thereof
The present invention relates to synthetic proteins and the uses thereof. More particularly, the invention relates to synthetic circovirus type capsid proteins with improved properties.
12/11/14
20140363432
Vascular endothelial cell growth factor antagonists and uses thereof
The present invention provides vascular endothelial cell growth factor (vegf) antagonists and methods of using vegf antagonists. Vegf antagonists contemplated by the invention include vegf antibodies and vegf receptor fusion proteins.
12/11/14
20140363426
Heterodimeric proteins
In one aspect, the present invention provides heterodimeric antibodies comprising a first monomer comprising a first heavy chain constant domain comprising a first variant fc domain and a first antigen binding domain and a second monomer comprising a second heavy chain constant domain comprising a second variant fc domain and a second antigen binding domain. In an additional aspect the heterodimeric antibody comprises a first monomer comprising a heavy chain comprising a first fc domain and a single chain fv region (scfv) that binds a first antigen, wherein the scfv comprises a charged scfv linker.
12/11/14
20140363423
Peptide compounds for inhibition of platelet aggregation
The invention relates to a peptide compound and its pharmaceutical composition for inhibiting platelet aggregation and preventing/treating thrombogenic diseases. The invention develops pentapeptides and hexapeptides derived from snake venom c-type lectin-like proteins (clps) fragments, which can inhibit platelet aggregation and have antithrombotic activity without hemorrhagic tendency.
12/11/14
20140363422
Method of providing monoclonal auto-antibodies with desired specificity
Provided are novel binding molecules of human origin, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize antigens such as native endogenous proteins associated with, e.g., immune response, autoimmune disorders, inflammatory diseases, metabolic disorders, vascular function, neurodegenerative diseases or tumors. More particularly, a human auto-immunosome and corresponding monoclonal antibody reservoir are provided.
12/04/14
20140359900
Production of dha and other lc pufas in plants
The invention provides recombinant host organisms genetically modified with a polyunsaturated fatty acid (pufa) synthase system and one or more accessory proteins that allow for and/or improve the production of pufas in the host organism. The present invention also relates to methods of making and using such organisms as well as products obtained from such organisms..
12/04/14
20140359836
Isolated novel nucleic acid and protein molecules from corn and methods of using those molecules to generate transgenic plant with enhanced agronomic traits
This disclosure provides purified nucleic acids and polypeptides. Also provided are transgenic plants, seeds, and plant cells containing dna for expression of the proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants, methods of making such plants and methods of making agricultural commodity including seeds and hybrid seeds from such plants..
12/04/14
20140359798
Correction of crb1 mutations
Genetically engineered mice having a corrected cbr1rd8 mutation and methods for correcting the cbr1rd8 mutation to produce the genetically engineered mice are provided according to aspects of the present invention. Kits, expression vectors and fusion proteins according to aspects of the invention are provided for use to produce the genetically engineered mice characterized by a corrected cbr1rd8 mutation..
12/04/14
20140357854
Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
12/04/14
20140357853
Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
12/04/14
20140357852
Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
12/04/14
20140357851
Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
12/04/14
20140357850
Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
Antigen binding proteins that interact with proprotein convertase subtilisin kexin type 9 (pcsk9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to pcsk9 are described.
12/04/14
20140357666
Compounds for inhibiting the interaction of bcl2 with binding partners
The present invention relates to compounds of formula i: in which r1, r2, r3 and r4 are as defined in the summary of the invention. Compounds of formula i are capable of disrupting the bcl-2 interations with proteins containing a bh3 domain.
12/04/14
20140357665
Opsin-binding ligands, compositions and methods of use
Compounds are disclosed that are useful for treating ophthalmic conditions caused by or related to production of toxic visual cycle products that accumulate in the eye, such as dry adult macular degeneration, as well as conditions caused by or related to the misfolding of mutant opsin proteins and/or the mis-localization of opsin proteins. Compositions of these compounds alone or in combination with other therapeutic agents are also described, along with therapeutic methods of using such compounds and/or compositions.
12/04/14
20140357659
Method for predicting and evaluating responsiveness to cancer treatment with dna-damaging chemotherapeutic agents
Provided herein are methods directed to the prediction and early assessment of the efficacy of cancer treatment regimens, in particular in patients undergoing therapy with a dna-damaging chemotherapeutic agent, by determining expression levels of certain proteins found to be useful as biomarkers in circulating tumor cells obtained from the patient both prior to and post-treatment.. .
12/04/14
20140357633
Compounds for inhibiting the interaction of bcl2 with binding partners
The present invention relates to compounds of formula i: in which r1, r2, r3 and r4 are as defined in the summary of the invention. Compounds of formula i are capable of disrupting the bcl-2 interations with proteins containing a bh3 domain.
12/04/14
20140357566
Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands
The invention relates to a new polynucleotide which encodes a polypeptide expressed in the salivary glands of ticks, more particularly the ixodes ricinus arthropod tick, during the slow-feeding phase of the blood meal have, said polynucleotide and related polypeptide may be used in different constructions and for different applications which are also included in the present invention.. .
12/04/14
20140357565
Method of producing factor viii proteins by recombinant methods
Provided herein are methods and compositions for producing factor viii proteins. Such methods include introducing into a cell a nucleic acid molecule encoding a factor viii protein operably linked to a promoter, wherein the promoter is characterized by the ability to produce commercially viable factor viii protein; and incubating the cell under conditions for producing commercially viable factor viii protein.
12/04/14
20140357521
Tools and methods for expression of membrane proteins
The disclosure relates cells or cellular systems that express both a membrane protein and a binding domain directed to the membrane protein. Also, methods are provided that use such cells or cellular systems to produce higher amounts of the membrane proteins.
12/04/14
20140357510
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins futrin 1, 2, 3 and/or 4 (=r-spondin 2, 3, 1 and 4, respectively), e.g. In connection with tumors or diseases of the muscle, kidneys or bones.
12/04/14
20140357508
Cell surface display, screening and production of proteins of interest
Aspects of the invention provide compositions and methods for displaying engineered polypeptides on a cell surface. According to aspects of the invention, immobilized polypeptides can be screened to identify one or more variants having one or more functional or structural properties of interest.
12/04/14
20140356966
Method and apparatus for detection of biological conditions
A system and method for analysis of fluids, particularly bodily fluids such as saliva, uses an active, electrically-driven substrate for supporting an amalgamate of fluid and nanoparticles selected to adhere to one or more proteins. The nanoparticles affect light that is directed on or through the amalgamate.
12/04/14
20140356934
Incubation chamber
An incubation chamber (10) having a water reservoir (12) has a climate controlling device, which makes it possible to set a desired temperature, as well as an object holder (18) for biological or chemical specimens. To make defined and replicable conditions possible, for instance for digestion processes of proteins, it is proposed that the climate controlling device has two separate climate zones (14, 16), which can be regulated separately from one another, a first climate zone (14) being located in the vicinity of the cover of the chamber (10)..
12/04/14
20140356910
Methods for increasing mannose content of recombinant proteins
The present invention relates to methods of upregulating the high mannose glycoform content of a recombinant protein during a mammalian cell culture by manipulating the mannose to total hexose ratio in the cell culture media formulation.. .
12/04/14
20140356909
Il-17 binding proteins
Proteins that bind il-17 and/or il-17f are described along with their use in composition and methods for treating, preventing, and diagnosing il-17 related diseases and for detecting il-17 in cells, tissues, samples, and compositions.. .
12/04/14
20140356906
Methods and products for transfecting cells
The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using rna are disclosed.
12/04/14
20140356905
Mammalian cell culture system for large-scale expression of recombinant proteins
Compositions and methods for large-scale recombinant protein expression are disclosed.. .
12/04/14
20140356896
Transmembrane protein as biosensors
The disclosure relates to engineered transport proteins comprising at last one fluorescent reporter covalently bound to the transporter protein, wherein the transporter proteins comprise a structural inverted repeat motif, with the motif comprising a first and second subunit that are structural inverted repeats of one another and that are joined to one another by a polypeptide loop.. .
12/04/14
20140356510
Production of pulse protein products with reduced astringency
Pulse proteins of reduced astringency are obtained by fractionating pulse protein products which are completely soluble and heat stable in aqueous media at acid ph value of less than about 4.4 into lower molecular weight, less astringent proteins and higher molecular weight, more astringent proteins.. .
12/04/14
20140356496
Method and apparatus for the preparation of a crisp food product
A crisp food product is prepared in a first phase from thin food pieces of raw fruit, vegetable or gelatinizable proteins, by blanching them (if necessary) and drying them. A second phase takes place in a vacuum chamber, where the dried thin food pieces are exposed to heat to expand them, are quickly removed from the heat source and are cooled, before being removed from the vaccuum..
12/04/14
20140356478
Fusion of bioactive molecules
Fusion-proteins containing an enzyme, preferably a feed or food enzyme, coupled to a gut surface-binding domain are presented. The fusion-proteins can be used to promote feed utilization in animals.
12/04/14
20140356418
Compositions for binding to amyloid proteins
Compositions useful for the prevention and/or treatment of alzheimer's disease are disclosed. The composition comprises carrier particles each linked to a plurality of peptide constructs comprising a peptide binding sequence capable of binding to an amyloid protein and a transit amino acid sequence linked to said binding sequence.
12/04/14
20140356389
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
Disclosed herein are various open reading frames from a strain of e. Coli responsible for neonatal meningitis (mnec), and a subset of these that is of particular interest for preparing compositions for immunising against mnec infections..
12/04/14
20140356381
Methods of purifying heterodimeric proteins using immunoglobulin class switching
The present invention describes novel immunoglobulin compositions that co-engage at least two antigens, e.g. A first and second antigen, or, as outlined herein, three or four antigens can be bound, in some of the scaffold formats described herein.
12/04/14
20140356380
Neutralizing antibodies and methods of use thereof
This invention provides monoclonal antibodies that recognize the toll-like receptor 4/md-2 receptor complex, and monoclonal antibodies that recognize the tlr4/md2 complex as well as tlr4 when not complexed with md-2. The invention further provides methods of using the monoclonal antibodies as therapeutics.
12/04/14
20140356371
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
The present invention provides methods for reducing various lipoprotein fractions in the serum of patients. The methods of the invention include reducing serum remnant cholesterol, and/or the serum concentration of one or more ldl-c subfractions in a patient.
12/04/14
20140356364
Anti-b7-h4 antibodies and their uses
The present invention relates to antibodies (including anti-b7-h4 antibodies) and their antigen-binding fragments and to other molecules (including fusion proteins that bind to the cognate antigen/receptor, etc.) that are capable of immunospecifically binding to b7-h4 and the uses of such molecules in the diagnosis and the treatment of cancer and other diseases. The invention particularly concerns the use of such molecules to retard or prevent tumor growth, inhibit tumor-mediated suppression, eliminate tumors and/or deplete or block the activity of tumor associated macrophages (“tams”) so as to alter their activity and/or decrease tam—mediated immune suppression..
12/04/14
20140356363
Antigen binding proteins that bind pd-1
There is disclosed compositions and methods relating to or derived from anti-pd-1 antibodies. More specifically, there is disclosed fully human antibodies that bind pd-1, pd-1-binding fragments and derivatives of such antibodies, and pd-1-binding polypeptides comprising such fragments.
12/04/14
20140356362
Targeted/immunomodulatory fusion proteins and methods for making same
The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, to nucleotide sequences encoding the fusion proteins, wherein the chimeric fusion proteins comprises at least one targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.. .
12/04/14
20140356355
Il-17 receptor a antigen binding proteins
The present invention relates to il-17 receptor a (il-17ra or il-17r) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases mediated by il-17 receptor a activation by one or more il-17 ligands. The present invention relates to the identification of neutralizing determinants on il-17 receptor a (il-17ra or il-17r) and antibodies that bind thereto.
12/04/14
20140356348
Methods of predicting and decreasing the risk of pregnancy loss
Described are methods for diagnosing and predicting the risk of pregnancy loss in a subject based on the presence of an aberrant humoral response to three proteins, apolipoprotein b-100, alpha2macrogloblin (alpha2m), and fibronectin. The presence or a detectable level of maternal igg antibodies to trophoblast-derived fibronectin and/or apob-100, and/or the absence or a non-detectable level of antibodies specifically binding to alpha2m is associated with a history of rpl and an increased risk of pregnancy loss.
12/04/14
20140356346
Modified coagulation factor viia with extended half-life
The present invention relates to the fields of factor vii (fvii) and factor viia (fviia) albumin linked polypeptides. More specifically, the invention relates to cdna sequences coding for human factor vii and factor viia and derivatives genetically fused to a cdna coding for human serum albumin which may be linked by oligonucleotides which code for intervening peptidic linkers such encoded derivatives exhibiting improved stability and extended functional plasma half-life, recombinant expression vectors containing such cdna sequences, host cells transformed with such recombinant expression vectors, recombinant polypeptides and derivatives which do have biological activities of the unmodified wild type protein but having improved stability and prolonged shelf-life and processes for the manufacture of such recombinant proteins and their derivatives.
12/04/14
20140356345
New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus
The invention relates to a new family of proteolytic enzymes having the ability to hydrolize at a p h between 3 and 8 gluten olygopeptides which are resistant to cleavage by gastric and pancreatic enzymes and whose presence in the intestinal lumen results in toxic effects. The enzymes have been identified as endopeptidases of the s8/s53 family and are produced by an actinoallomurus strain.
12/04/14
20140356344
Mirac proteins
This disclosure relates to a method of generating conditionally active biologic proteins from wild type proteins, in particular therapeutic proteins, which are reversibly or irreversibly inactivated at the wild type normal physiological conditions. For example, evolved proteins are virtually inactive at body temperature, but are active at lower temperatures..
12/04/14
20140356326
Biologically active proteins having increased in vivo and/or in vitro stability
The present invention provides unstructured recombinant polymers (urps) and proteins containing one or more of the urps. The present invention also provides microproteins, toxins and other related proteinaceous entities, as well as genetic packages displaying these entities.
12/04/14
20140356322
Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins that are degraded and/or otherwise inhibited by bifunctional compounds of the present invention. In particular, the present invention is directed to compounds, which contain on one end a vhl ligand that binds to the ubiquitin ligase and on the other end a moiety that binds a target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein.
12/04/14
20140356320
Polyoma virus jc peptides and proteins in vaccination and diagnostic applications
The present invention relates to the field of vaccination or immunization, in particular therapeutic vaccination, and diagnosis. Pharmaceutical compositions and kits capable of eliciting a protective immune response against polyoma virus jc (jcv) are disclosed, which may be used e.g., for therapy or for prevention of progressive multifocal leukoencephalopathy (pml) and/or progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome (pml-iris).
12/04/14
20140356319
Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
The present invention describes peptides comprising phycocyanobilin (pcb), as well as the medical use of said peptides and that of pcb, due to the neuroprotector and/or neuroregenerative effects identified for them. Furthermore, pharmaceutical combinations of said peptides and of pcb with proteins or other peptides with synergic effect justify their use for ischemic or neurodegenerative cns disease treatment..
12/04/14
20140356289
Multisomes: encapsulated droplet networks
The invention provides a droplet encapsulate comprising: a drop of a hydrophobic medium; a peripheral layer of non-polymeric amphipathic molecules around the surface of the drop; and an aqueous droplet within the peripheral layer, the aqueous droplet comprising: (a) an aqueous medium and (b) an outer layer of non-polymeric amphipathic molecules around the surface of the aqueous medium. The invention also provides processes for preparing the droplet encapsulates.
12/04/14
20140356281
Dual specific binding proteins directed against il-1 and/or il-17
Engineered multivalent and multispecific binding proteins that bind il-1β and/or il-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Proteins for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Proteins with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.284

3583

4 - 0 - 80